BPH (Benign Prostatic Hyperplasia): Symptoms and Treatment

—————————————————————-

Roughly half of men in their 50s, and a large majority of men in their 80s, develop some degree of prostate enlargement, making it one of the most common conditions of male aging. BPH, short for benign prostatic hyperplasia, is the non-cancerous overgrowth of glandular and stromal tissue inside the prostate that gradually squeezes the urethra. The result is a familiar set of urinary symptoms: a weak stream, hesitancy, frequency, and waking up several times a night to urinate. It is bothersome and common — but, importantly, it is benign.

What BPH Is and Isn’t

The prostate sits beneath the bladder, wrapped around the urethra like a doughnut. As men age, hormonal shifts driven largely by dihydrotestosterone (DHT) prompt cells in the transitional zone to multiply. The gland grows, and that added bulk presses inward on the urethra. Per the NIDDK, an enlarged prostate does not turn into cancer and does not raise the risk of prostate cancer. They are different conditions that happen to affect the same organ.

That distinction matters because the workup for urinary symptoms in older men routinely uncovers both. Many patients arrive worried about cancer and leave with a benign hyperplasia diagnosis, while others turn out to need both conditions monitored. Reassurance about the “benign” part is warranted, but it does not mean the symptoms should simply be tolerated if they are affecting your life.

Symptoms and the IPSS Score

Urologists group BPH symptoms into storage and voiding categories. Storage symptoms include urgency, frequency (needing to go more often than about every two hours during the day), and nocturia, the medical term for nighttime urination. Voiding symptoms include hesitancy, a weak or intermittent stream, dribbling at the end of urination, and a sense of incomplete emptying. Many men also notice they have to bear down to start the stream.

The American Urological Association uses the International Prostate Symptom Score (IPSS), a seven-question form scored 0 to 35. Scores of 0 to 7 are mild, 8 to 19 are moderate, and 20 to 35 are severe. The questionnaire helps quantify symptoms and track response to treatment, but the number is a tool to guide the conversation, not a treatment decision by itself.

Causes and Risk Factors

Age is the dominant factor. By age 60, a majority of men have histologic evidence of BPH on biopsy or autopsy, and that share keeps climbing with each decade. Family history matters too: men whose fathers or brothers needed BPH treatment have higher odds of needing it themselves, especially when symptoms appear before age 60. Obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease are all associated with faster prostate growth and worse symptoms, possibly through chronic low-grade inflammation and hormonal effects. These are associations rather than proven causes.

Ancestry appears to play a role as well. Research summarized by sources such as Mayo Clinic suggests men of African descent often experience earlier and more severe symptoms, while some Asian populations have historically reported lower rates — though those gaps appear to narrow as diets and lifestyles change. Individual risk still varies widely.

How BPH Is Diagnosed

A primary care or urology visit usually starts with the IPSS, a focused history, and a digital rectal exam (DRE) to estimate prostate size and texture. A PSA blood test is often added because BPH can elevate PSA, and any concerning result prompts further evaluation. For more on interpreting that number, the PSA test guide walks through reference ranges, density, and velocity — and why PSA is never a stand-alone cancer test.

A urinalysis rules out infection or microscopic blood. Some clinicians order a post-void residual (PVR) measurement to see how much urine remains in the bladder after voiding; a PVR over roughly 100 to 150 mL suggests incomplete emptying. Uroflowmetry measures stream speed, with peak flows under about 10 mL per second considered low. Cystoscopy, prostate imaging, and other studies are reserved for selected cases. Prostatitis can mimic BPH symptoms and is part of the differential, particularly in younger men. Which tests you actually need is a clinical judgment, not a fixed checklist.

Treatment Options

There is no single best treatment for everyone; the right path is individualized and decided with a clinician based on symptom severity, prostate size, other health conditions, and personal priorities such as preserving sexual function. Mild symptoms with a low IPSS often need nothing beyond watchful waiting and lifestyle adjustments: limiting fluids before bed, cutting caffeine and alcohol, and double-voiding to empty more completely. Pelvic floor exercises help some men with mixed symptoms.

Medications

Alpha-blockers such as tamsulosin, alfuzosin, and silodosin relax smooth muscle in the prostate and bladder neck, easing flow within days. They do not shrink the gland. 5-alpha reductase inhibitors (5-ARIs) such as finasteride and dutasteride block the conversion of testosterone to DHT, gradually reducing prostate volume by roughly 20 to 30 percent over 6 to 12 months, and they also lower PSA by about half — something your clinician needs to know when interpreting PSA. Combination therapy can outperform either drug alone in men with larger glands, as the MTOPS and CombAT trials demonstrated. Daily tadalafil 5 mg (a PDE-5 inhibitor) is FDA-approved for BPH and is particularly useful when erectile dysfunction coexists. A beta-3 agonist such as mirabegron, or an anticholinergic, may be added for storage-predominant symptoms in selected patients. All of these have trade-offs and potential side effects, so they should be started and adjusted with a clinician rather than self-managed.

Procedures and Surgery

When medication is insufficient or complications develop, several procedural options exist, and the choice is highly individualized. Transurethral resection of the prostate (TURP) remains a long-standing benchmark, though newer minimally invasive techniques now handle many cases. Per the AUA’s 2023 guideline amendment (published in 2024), these options include UroLift (a prostatic urethral lift that uses small implants to retract obstructing tissue without cutting, typically for glands around 30 to 80 grams without a median lobe), Rezum (water-vapor thermal therapy, also generally for glands around 30 to 80 grams), and Aquablation (a robot-guided waterjet), for which the guideline notes that long-term retreatment data are still maturing. iTIND is an office-based, temporarily implanted device option. Holmium laser enucleation (HoLEP) and simple prostatectomy are options for larger glands, and prostatic artery embolization (PAE), performed by interventional radiologists, is another approach. Each option carries different trade-offs in recovery time, effect on ejaculation and sexual function, and durability, which a urologist can walk through in detail for your specific situation.

Treatment at a Glance

This table is a general overview, not a treatment plan; the right choice depends on your prostate size, symptoms, and health, and is decided with a urologist.

When to See a Doctor

Bothersome urinary symptoms, blood in the urine, recurrent urinary tract infections, sudden difficulty urinating, or significant sleep disruption from nocturia all warrant medical evaluation. Left untreated, severe BPH can occasionally lead to bladder damage, kidney injury, or chronic urinary retention, which is one reason worsening symptoms should not simply be ignored. A urologist can help match treatment to your situation.

When to seek emergency care: Call 911 or go to the nearest emergency room if you experience a complete inability to urinate (acute urinary retention), severe lower-abdominal pain with a distended bladder, blood clots in the urine that block flow, or a fever above 101°F with urinary symptoms suggesting a serious infection (urosepsis).

Frequently Asked Questions

Does BPH increase the risk of prostate cancer?

No. BPH and prostate cancer arise in different zones of the gland and through different mechanisms. Having an enlarged prostate does not raise cancer risk, although both conditions become more common with age and can be diagnosed in the same man.

How long do BPH medications take to work?

Alpha-blockers usually produce noticeable improvement within a few days to two weeks. 5-alpha reductase inhibitors work more slowly because they shrink the gland, with peak benefit around 6 to 12 months.

Can BPH cause erectile dysfunction?

BPH itself does not directly cause ED, but the two conditions share risk factors and often coexist. Some BPH treatments, particularly 5-ARIs and certain procedures, can affect libido, erections, or ejaculation in a minority of men, which is worth discussing before starting treatment.

Is BPH surgery permanent?

Most surgical and minimally invasive procedures provide durable symptom relief for years, though the exact durability varies by technique and some men eventually need a second procedure as the prostate continues to grow. Your urologist can explain the expected durability of each option.

What to Do Next

If urinary symptoms are interfering with sleep or daily life, a reasonable first step is a primary care or urology visit with an IPSS, urinalysis, and PSA. From there, treatment is genuinely individualized: small glands with mild symptoms may need only lifestyle changes, while larger glands or worse symptoms often respond to medication, with procedures available when drugs fall short. The current generation of minimally invasive options has widened the choices considerably, so a man who was told a decade ago that major surgery was the only answer may have better, less invasive options today — a conversation worth having with a urologist.